30 August 2017
Today sees the publication of the Government commissioned Life Science Industrial Strategy report. This report sets out the findings of an independent sector-led review, led by Professor Sir John Bell, into the £64 billion UK life sciences industry and sets out proposals to help the UK's life sciences sector become an international benchmark for success. This report will inform the basis of Government work with the sector towards a Sector Deal in the coming months. In response to the publication of this report, the British Society for Immunology has released the following statement:
Commenting on the publication of the Life Sciences industrial strategy, Professor Anne Cooke, Vice-President of the British Society for Immunology, said:
“The UK is a world leader in life sciences research and immunology sits at the sharp end of this innovation. It is wonderful to see how decades of investment and research into immunity are now yielding breakthroughs in the treatment of critical disease areas such as infection, cancer, autoimmunity and allergy.
“We are pleased to see such an ambitious plan laid out by Professor Sir John Bell to boost the UK’s capacity to deliver on new vaccines from basic research through to production through the announcement of a Vaccine Development and Manufacturing Centre. This is a vital addition to our capacity to respond to the future health requirements of the country.
“The life sciences industry is a key driver of our economy and in the UK, has a unique and fruitful partnership with the NHS and with universities. The strategy rightly focuses on many actions we have been calling for, including maximising the research potential of the NHS, reinforcing funding for basic and translational research and making it attractive for talented and skilled researchers worldwide to come and work here.
“There is a lot of uncertainty in the research community currently, and we hope this report’s recommendations will lead to firm actions to strengthen and deepen collaborations between the life science sectors.”
Our report 'Immunology and the UK's life sciences industry' is our response to the Government's industrial strategy Green Paper. The report makes a number of recommendations that fall under seven priority actions to ensure the future success of the UK's life sciences industry.